Jennison Associates’s Dentsply Sirona XRAY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
– Sell
-1,072,322
Closed -$12.4M – 634
2026
Q1
$12.4M Buy
+1,072,322
New +$13.4M 0.01% 364
2024
Q1
– Sell
-582,764
Closed -$20.7M – 637
2023
Q4
$20.7M Buy
+582,764
New +$18.5M 0.02% 325
2022
Q4
– Sell
-613,523
Closed -$17.4M – 636
2022
Q3
$17.4M Buy
613,523
+155,593
+34% +$5.32M 0.02% 330
2022
Q2
$16.4M Buy
+457,930
New +$18.5M 0.02% 335
2017
Q1
– Sell
-3,769
Closed -$218K – 807
2016
Q4
$218K Buy
+3,769
New +$223K ﹤0.01% 787

Other funds holding XRAY

Jennison Associates's XRAY Position: Q2 2026 in Review

Jennison Associates sold out of Dentsply Sirona (XRAY) in Q2 2026, closing a stake of 1,072,322 shares — an estimated $12.4M sold.

Jennison Associates first reported a position in XRAY in Q4 2016 and held it in 5 quarters. The position peaked at $20.7M in Q4 2023. 377 funds tracked by Wall St. Rank hold XRAY as of Q2 2026.

  • Jennison Associates reported no remaining Dentsply Sirona position as of Q2 2026 after selling out during the quarter.
  • Jennison Associates sold 1,072,322 Dentsply Sirona shares in Q2 2026, an estimated $12.4M.
  • Jennison Associates first reported a position in Dentsply Sirona in Q4 2016 and held it in 5 quarters.
  • Jennison Associates's Dentsply Sirona position peaked at $20.7M in Q4 2023.
  • 377 funds tracked by Wall St. Rank held Dentsply Sirona as of Q2 2026.

Based on Jennison Associates's 13F filing for Q2 2026, filed 3 Aug 2026.